Santen Pharm CO ADR (SNPHY)

12.73
+0.78 (6.52%)
OP · Last Trade: Nov 9th, 2:50 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close11.95
Open12.70
Bid-
Ask-
Day's Range12.67 - 12.78
52 Week Range9.500 - 13.93
Volume1,147
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume2,591

Chart

News & Press Releases

Santen Joins Inaugural Global Summit for Eye Health as High-Impact Partner
By Santen Pharmaceutical Co., Ltd. · Via JCN Newswire · August 5, 2026
SNPHY Stock Earnings: Santen Pharmaceutical Reported Results for Q4 2023investorplace.com
Santen Pharmaceutical just reported results for the fourth quarter of 2023.
Via InvestorPlace · May 17, 2024
Current Analysis: Santen Pharmaceuticaltalkmarkets.com
Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. Over the past year, Santen's share price rose about 32% from $7.60 to $10.01 as of Thursday’s market close
Via Talk Markets · February 15, 2024